Combination Chemo, Peripheral Stem Cell Transplant, Biological Therapy, Pamidronate and Thalidomide for Multiple Myeloma

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

April 13, 1999

Primary Completion Date

January 9, 2018

Study Completion Date

January 9, 2018

Conditions

Multiple Myeloma and Plasma Cell Neoplasm

Interventions

BIOLOGICAL

filgrastim

BIOLOGICAL

recombinant interferon alfa

DRUG

busulfan

DRUG

cyclophosphamide

DRUG

melphalan

DRUG

pamidronate disodium

DRUG

thalidomide

PROCEDURE

peripheral blood stem cell transplantation

Trial Locations (2)

Banner Good Samaritan Medical Center, Phoenix

City of Hope Comprehensive Cancer Center, Duarte

All Listed Sponsors

collaborator

National Cancer Institute (NCI)

NIH

lead

City of Hope Medical Center

OTHER